Multimodality Cardiac Imaging in COVID-19 Infection
- PMID: 37512035
- PMCID: PMC10384118
- DOI: 10.3390/medicina59071223
Multimodality Cardiac Imaging in COVID-19 Infection
Abstract
COVID-19 infection often produces cardiovascular complications, which can range from mild to severe and influence the overall prognosis. Imaging is the cornerstone for diagnosing initial COVID-19 cardiovascular involvement as well as treatment guidance. In this review, we present the current state of the literature on this subject while also emphasizing possible algorithms for indicating and executing these investigations.
Keywords: COVID-19; cardiac magnetic resonance; echocardiography; multimodality imaging; myocarditis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





References
-
- Esposito A., Palmisano A., Cao R., Rancoita P., Landoni G., Grippaldi D., Boccia E., Cosenza M., Messina A., La Marca S., et al. Quantitative assessment of lung involvement on chest CT at admission: Impact on hypoxia and outcome in COVID-19 patients. Clin. Imaging. 2021;77:194. doi: 10.1016/j.clinimag.2021.04.033. - DOI - PMC - PubMed
-
- Lopes R.D., Macedo A.V.S., de Barros E Silva P.G.M., Moll-Bernardes R.J., Dos Santos T.M., Mazza L., Feldman A., D’Andréa Saba Arruda G., de Albuquerque D.C., Camiletti A.S., et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021;325:254. doi: 10.1001/jama.2020.25864. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical